FDA's Regulation of Drug & Device Promotion via the Internet & Social Media

Special Report: Summary of Reader Survey On September 21, 2009, the FDA issued a notice of public hearing and requested for comments on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. Public Docket No. FDA-2009-N-0441, CDER 200994, was opened and accepted comments through February 28, 2010. The FDA asked for comments relating to the following 5 issues: Issue 1: Accountability Issue 2: Fulfilling Regulatory Requirements Issue 3: Posting Corrective Information Issue 4: Links Issue 5: Adverse Event Reporting Under each issue, the FDA included several specific questions for which it was seeking answers. Beginning on September 21, 2009, Pharma Marketing News hosted an online survey/questionnaire that included all 19 of these specific questions. For most questions, the survey included specific choices that respondents could select as part of their answer. Each question also allowed respondents to enter comments. The goal of was to obtain both quantitative and qualitative answers to the questions posed by the FDA. The survey was closed on February 26, 2010 after collecting responses from 274 people. A summary of the results--including 731 comments--is presented in this report. Read this article now. It's FREE... Download PDF file

FDASM-SURVEY
Published February 2010

Find other articles in related Topic Areas:

• eMarketing and ePromotion
• Regulatory Compliance